FDA ANDA · ANDA201833

SODIUM CHLORIDE

Sponsor: HIKMA

APPLICATION

ANDA201833

TYPE

ANDA

ORIGINAL APPROVAL

2013-09-24

LATEST ACTION

2013-09-24

ROUTE

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, INJECTION

DOSAGE FORM

SOLUTION

MARKETING STATUS

Prescription

Products

SODIUM CHLORIDE 0.9%Prescription

SODIUM CHLORIDE 90MG/10ML (9MG/ML) · SOLUTION · INJECTION

SODIUM CHLORIDE 0.9%Prescription

SODIUM CHLORIDE 18MG/2ML (9MG/ML) · SOLUTION · INJECTION

2013-09-24UNKNOWN · OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.